EMA Aims For Better Info On Benefit-Risk Balance To Support Drug Choices In Pregnancy
Executive Summary
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
You may also be interested in...
EMA Gets Specific On Pharmacovigilance Of Drugs Used In Pregnancy
A new EU guideline offers recommendations for facilitating appropriate pharmacovigilance for drugs that may be used in pregnant or breastfeeding women.
Pregnancy Registries Are Insufficient To Assess Drug Safety, US FDA Says
Draft guidance recommends complementary studies to evaluate effects of drug use during pregnancy; FDA may require lactation studies more frequently.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.